covid spike antibody test results range

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency. At this time, SARS-CoV-2 antibody tests do not tell you if: A: Antibodies are proteins made by your body's immune system to help fight off infections, including those caused by viruses. According to my test report from LabCorp, a result of 0.8 units per milliliter (U/mL) or higher indicates the presence of SARS-CoV-2 antibodies. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Individuals tested are required to receive patient fact sheets as part of the tests Emergency Use Authorization (EUA). Woo PC, Lau SK, Wong BH, et al. Incubate 45 min at RT. Screening testing may be most valuable in certain settings where early identification is essential to reducing transmission and mitigating risk for severe disease among populations at high risk. Massetti GM, Jackson BR, Brooks JT, et al. Clinical trials and other studies are under way to better understand immunity to SARS-CoV-2. A highly specific test will identify most people who truly do not have antibodies, and a small number of people without antibodies may be identified as having antibodies by the test (false positives). Each individual sample was tested in . If a person tests positive on a screening test and is referred for a confirmatory test, they should isolate until they receive the results of their confirmatory test. If a high positive predictive value cannot be achieved with a single test result, two tests may be used together to help identify individuals who may truly be SARS-CoV-2 antibody positive. In general, more severe disease tends to lead to. A positive serological result is not diagnostic but indicates that an individual has likely been infected with SARS-CoV-2 and produced an immune response to the virus. Specificity is the ability of the test to correctly identify people without antibodies to SARS-CoV-2. If someone had exposure to another person with COVID-19, but the exposed individual has had COVID-19 within the past 30-90 days,* consider using antigen tests (rather than an NAAT, such as a PCR test) to identify a new infection. Your legs would be the stem. This test is only authorized for the duration of the declaration that circumstances exist, justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. Colds, allergies, the flu and respiratory syncytial virus (RSV) are an inevitable part of autumn and winter. A semi-quantitative antibody test can help identify individuals who have developed an immune response after exposure to COVID-19 or vaccination. The design of the tests - different antibody tests may detect different antibodies, The performance of the tests, including the sensitivity and specificity of each test (see. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. These tests measure the number of antibodies in a patient sample. The neutralising antibody levels at 8 weeks after the first dose were 157 IU/mL (GM 167) and 757 IU/mL (GM 623), respectively. For the pandemic, weve mostly ended up with semi-quantitative antibody testing. All Rights Reserved. This research was supported by the National Institutes of Health (grant NIH U19 AI142790-02S1), the GHR Foundation, the Swiss National Science Foundation Early Postdoc Mobility Fellowship (P2EZP3_195680), a Postdoc Mobility Fellowship (P500PB_210992), and an American Association of Immunologists Career Reentry Fellowship. Costs for NAATs If you request a test through your doctor, there is no upfront cost. Revised to align with CDC recommendations for fully vaccinated individuals, Expansion on the description of categories of tests, choosing a test, and addition of intended uses of testing, Addition of health equity considerations related to testing, including discussion on ensuring equitable testing access and availability, Discussion on expanded availability to, and use of, screening tests to reduce asymptomatic spread, Discussion on testing of vaccinated individuals and interpretation of test results, Inclusion of links to setting-specific testing guidance, Due to the significance of asymptomatic and pre-symptomatic transmission, this guidance further reinforces the need to test asymptomatic persons, including, Diagnostic testing categories have been edited to focus on testing considerations and actions to be taken by individuals undergoing testing, Except for rare situations, a test-based strategy is no longer recommended to determine when an individual with a SARS-CoV-2 infection is no longer infectious (i.e., to discontinue Transmission-Based Precautions or home isolation), Added screening to possible testing types, Removed examples please refer to setting specific guidance. The imaging work revealed that two of the promising antibodies bind to the SARS-CoV-2 Spike by latching onto two parts of the protein at once. It is not known at this time whether detectable antibody correlates with immunity. This test has not been FDA cleared or approved. Anti-SARS-CoV-2 spike antibody . This test has not been FDA cleared or approved. These cookies may also be used for advertising purposes by these third parties. Negative predictive values for SARS-CoV-2 antibody tests are also impacted by how common SARS-CoV-2 antibodies are in the population being tested at a certain time. Most people with COVID-19 have mild illness and can recover at home without medical care. When choosing which test to use, it is important to understand the purpose of the testing (diagnostic or screening), test performance in context of COVID-19 incidence, need for rapid results, and other considerations (See Table 1). Further analysis showed that the neutralizing antibodies fell into three groups, each binding to a different part of the RBD. Settings that should be prioritized for screening testing include facilities and situations where transmission risk is high and the population served is at high risk of severe outcomes from COVID-19 or there is limited access to healthcare, including: Serial screening testing is less effective at reducing COVID-19s impacts in settings where disease rates are lower, risk of spread is lower, and risk of severe illness is lower. Your results will be reported to public health authorities where required by law. When your physician orders antibody testing, often referred to as serology testing, they are looking for the presence of antibodies (qualitative testing) or the level of antibodies (quantitative testing) you have against a specific target, such as a virus. The Kruskal-Wallis test was used for comparing the percent inhibition of NAbs and anti-spike protein antibodies. If youve been infected with COVID-19, been vaccinated or been boosted (or any combination thereof), you might be interested in knowing your antibody level. Testing for SARS-CoV-2 Infection. The .gov means its official.Federal government websites often end in .gov or .mil. Additional authors of the study, Potent, omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before omicron emergence, were Fernanda A. Sosa Batiz, Dawid Zyla, Stephanie S. Harkins, Chitra Hariharan, Hal Wasserman, Michelle A. Zandonatti, Robyn Miller, Erin Maule, Kenneth Kim, Kristen Valentine, and Sujan Shresta. Some antibodies in your body may protect you from getting those infections. With the addition of an automated dilution, we are now able to report result 0.8-25000 U/mL with higher values reported as >25000 U/mL. Incubate 2.5 h at RT or O/N at 4C. Holiday gatherings. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Thirty serum sample from COVID-19 patients showing different titers of IgG (a) (range from 0.43 to 187.82) and IgM (b) (range from 0.26 to 24.02) were tested. Diagnostic testingis intended to identify current infection in individuals and is performed when a person has signs or symptoms consistent with COVID-19, or is asymptomatic, but has recent known or suspected exposure to someone with suspected or confirmed SARS-CoV-2 infection. They should not test until at least 5 days after their exposure. A positive antibody test result can help identify someone who has had COVID-19 in the past or has been vaccinated against COVID-19. More research is needed to understand the role of SARS-CoV-2 antibody testing in evaluating a person's immunity or protection against COVID-19 and understanding if antibody tests will be helpful for deciding if a person should receive a COVID-19 vaccine. Center for Infectious Disease and Vaccine Research, Inclusion, Diversity, Equity & Advocacy at LJI, The Tullie and Rickey Families SPARK Program, Learn more about LJI leadership of the Coronavirus Immunotherapy Consortium (CoVIC). For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. You will be subject to the destination website's privacy policy when you follow the link. Reactive (Positive, 50.0 AU/mL) results may be due to immunization or past or present infection with SARS-CoV-2. Together, these insights could help guide the design of vaccines or antibodies as potential treatments for COVID-19. This is screening testing that happens on a situational basis, for example, testing yourself before you visit an older relative who is at high risk of getting very sick from COVID-19. Preferred: 5 mL blood in GOLD SST tube.Also Acceptable: Orange RST, pearl PPT, serum from red top, plasma from EDTA tube. Provide insurance information and $6 fee for thenetwork of physicians (PWNHealth) who will review your request and generate a test order. At this time it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Laboratories that perform screening or diagnostic testing for SARS-CoV-2 must have a CLIA certificate and meet regulatory requirements. SARS-CoV-2 antibodies detected in your blood reflect only one part of your immune system, which also includes T-cells and other components that are part of your body's immune response. For more information, see the Antigen Test Algorithm. This expansion ensures that wait times both for testing and reporting of results are decreased, helping limit the spread of SARS-CoV-2. Nasal, Nasopharyngeal, Oropharyngeal, Sputum, Saliva, Varies by test, but generally high for laboratory-based tests and moderate-to-high for POC tests, Varies depending on the course of infection, Most 1-3 days. When you arrive at the Labcorp patient service center, a phlebotomist will take a blood sample. If antibodies give you this protection and how long this protection lasts can be different for each disease and each person. The job of an antibody is to grab on to a foreign invader in your body, or antigen. This flags the invader for elimination by other parts of the immune system. Overview of Testing for SARS-CoV-2, the virus that causes COVID-19, Centers for Disease Control and Prevention. Antibody tests for COVID-19 infection are used to detect antibodies against the SARS-CoV-2 virus. These assays, or evaluations, have not been correlated to one another so values generated by one assay cannot be compared to values generated by another. Screening testing can provide important information to limit transmission and outbreaks in high-risk congregate settings. Correlation with epidemiologic risk factors and other clinical and laboratory findings is recommended. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Those in the 250 to 500 range who are at low risk of exposure -- working from home, taking precautions -- should get a booster, "but there's no urgency." For those in the 500 to 1,000 range who. The U.S. Department of Health and Human Services has required laboratories and testing facilities to reportrace and ethnicity data to health departments, in addition to other data elements, for individuals tested for SARS-CoV-2 or diagnosed with COVID-19. A: No. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Labcorp.com. Viral tests can also be used as screening tests to reduce the transmission of SARS-CoV-2 by identifying infected persons who need to isolatefrom others. My test result was greater than 2,500 U/mL. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Antibody trajectories following SARS-CoV-2 infection. In fact, studies in mice suggest some of these antibodies may help prevent severe cases of COVID-19. Unfortunately, these tests cannot tell you how high or low your level is relative to others, or what your particular level may mean for protection. Increase public messaging about the importance of testing and communicate these messages in multiple languages and venues, particularly in communities at higher risk and disproportionately impacted by the virus. Labs & Appointments Toggle Labs & Appointments, Billing & Insurance Toggle Billing & Insurance, Diseases & Conditions Toggle Diseases & Conditions, OnDemand Testing Toggle OnDemand Testing, Testing by Disease & Condition Toggle Testing by Disease & Condition, Testing & Services For Toggle Testing & Services For, Hospitals & Physician Systems Toggle Hospitals & Physician Systems, Managed Care Health Plans Toggle Managed Care Health Plans, Lab Data Integrations & Tools Toggle Lab Data Integrations & Tools, Employee Wellness & Testing Toggle Employee Wellness & Testing, Government & Education Toggle Government & Education, Therapeutic Indications Toggle Therapeutic Indications, Development Phase Toggle Development Phase, Compounds & Molecules Toggle Compounds & Molecules. More information is available, Travel requirements to enter the United States are changing, starting November 8, 2021. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Since the beginning of the COVID-19 pandemic, theres been a lot of talk about testing. Add 100 l of TMB One-Step Substrate Reagent to each well. In vaccinated people: Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Based on evolving evidence, CDC recommends fully vaccinated people get tested 5-7 days after close contact with a person with suspected or confirmed COVID-19. Individuals may have detectable virus present for several weeks following seroconversion. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. If you'd like to know your antibody levels, you can get a test through Labcorp* by clicking here. You do not need to do anything to prepare for the test. An example of public health surveillance testing is when a state public health department samples a random percentage of all people in a city on a rolling basis to assess local infection rates and trends. https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html. Results are reported as AU/mL. While contingent on a variety of factors, this could be due to testing too early in the course of infection, the absence of exposure to the virus, or the lack of adequate immune response, which can be due to conditions or treatments that suppress immune function. This test checks for antibodies to COVID-19 after exposure or vaccination and provides a numerical value that indicates the level of antibodies present. For ChAdOx1, S-antibody levels reduced from a median of 1201 U/mL (IQR 609-1865) at 0-20 days to 190 U/mL (67-644) at 70 or more days. For additional information about COVID-19 testing, visit theFDAwebsite orCDCwebsite. Antibody tests do not tell you whether or not you can infect other people with SARS-CoV-2. Alfego and a team of Labcorp scientists analyzed results from tests used to detect antibodies that guard against "spike" and nucleocapsid proteins on the SARS-CoV-2 virus. SARS-CoV-2 antibody tests can help identify people who may have been infected with the SARS-CoV-2 virus or have. A positive antibody test could also mean the test is detecting antibodies in your blood in response to your COVID-19 vaccine. We evaluated the performance of 11 SARS-CoV-2 antibody tests using a reference set of heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some of whom contributed serial . It has also been reported that certain patients with confirmed infection do not develop SARS-CoV-2 antibodies. Although studies have shown antibodies bound to Spike before, this new research reveals how the original Moderna SARS-CoV-2 vaccine could prompt the body to produce antibodies against the later Omicron variants of SARS-CoV-2. Screening testingis intended to identify people with COVID-19 who are asymptomatic or do not have any known, suspected, or reported exposure to SARS-CoV-2. Northern Ireland - 95.3%. Usually, these antibody levels provide your physician insight as to the effectiveness of your immune response and sometimes ongoing immunity. In a new investigation, scientists from La Jolla Institute for Immunology (LJI) have shown how antibodies, collected from this clinical study volunteer, bind to the SARS-CoV-2 Spike protein to neutralize the virus. Add 100 l of standard or sample to each well. Coronavirus Disease 2019 (COVID-19). A negative serologic result indicates that an individual has not developed detectable antibodies at the time of testing. This finding is consistent with another recent Cell Reports study from the Saphire Lab showing the importance of bivalent antibodies against SARS-CoV-2 variants. Science. Antibody (or serology) tests are used todetect previous infection with SARS-CoV-2 and can aid in the diagnosis of multisystem inflammatory syndrome in children (MIS-C)and in adults (MIS-A)2. Aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. That means any antibodies made by the volunteer were a result of vaccination, rather than exposure to Omicron. If testing will be delayed more than 7 days store at -20C or colder. A: Predictive values are probabilities calculated using a test's sensitivity and specificity, and an assumption about the percentage of individuals in the population who have antibodies at a given time (which is called "prevalence" in these calculations). People who have had an exposure with someone known or suspected of having COVID-19 should be tested at least 5 days after the exposure. The incubation period for COVID-19 ranges from 5 to 7 days. Some strategies to achieve health equity in testing access and availability include: Positive test results using a viral test (NAAT, antigen or other tests) in persons with signs or symptoms consistent with COVID-19 indicate that the person has COVID-19, independent of vaccination status of the person. A: No. If they test negative, the antigen test should be repeated per FDA guidance. An official website of the United States government, : This test has been authorized by FDA under an Emergency Use Authorization (EUA). Visit http://www.fda.gov/medical-devices/safety-communications/antibody-testing-not-currently-recommended-assess-immunity-after-covid-19-vaccination-fda-safety for more information. Antibodies are among the immune systems most elite fighters. Current research shows that it may be best to get antibody testing 3 to 4 weeks after symptom onset or known exposure to COVID-19 to lower the chance of receiving a false positive or false negative result. Added Health Equity language for access of testing, Added information about other diagnostic tests for SARS-CoV-2, Revised to align with CDCs updated recommendations on, Revised to align with CDC recommendations for. The latest news, research, and COVID-19 testing information from Labcorp. We use cookies to analyze site traffic and to ensure that we give you the best experience on our website. This could mean that individuals may have developed antibodies to the virus even though the test indicated that they had not. You were directly exposed to the virus in the past 14 days. A: Results may be different for several reasons, including: For this and other reasons, you should always review your test results with your health care provider. Since the start of the year, youve undoubtedly been hearing more and more about Flurona. You may be asking yourself, Is this even possible? Having more antibodies means your body can fight infection better than having fewer antibodies. Copyright and Disclaimer, Department of Laboratory Medicine & Pathology, COVID-19 Testing Frequently Asked Questions For Patients, Frequently Asked Questions About COVID-19 Testing for Providers & Clients. Most COVID-19 vaccines create anti-S (spike protein) antibodies. Negative predictive value is higher in areas with low prevalence and lower in areas with high prevalence. Furthermore, waning of antibody titers has been reported in some individuals within a range of months after infection, a feature which has also been reported for other coronaviruses. 2022;185(3):457-466.e4. allowed for additional confirmatory or additional reflex tests. For more information, including on retesting persons previously infected with SARS-CoV-2, visit Ending Isolation and Precautions for People with COVID-19: Interim Guidance. This means that different tests may provide different results for the same blood sample. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. 2021 Laboratory Corporation of America Holdings and Lexi-Comp Inc. All Rights Reserved. Individuals without prior infection who have been . This is how some vaccines work: they prepare your body to fight off a real threat by tricking your system into producing antibodies to a simulated threat. Results: Positive . Where can I find my results? For more information, see CDCs COVID-19 isolationguidance. This structural work lets us see exactly how the antibodies interact with the protein and how they can neutralize the virus.. See FDAs list ofIn Vitro Diagnostics Emergency Use Authorizations for more information about the performance and interpretation of specific authorized tests. Many types of tests are used to detect SARS-CoV-2, 1 and their performance characteristics vary. The researchers then took these five remaining antibodies through another battery of tests. You have previously tested positive for COVID-19 infection and want to know if you have detectable antibodies. If someone has become newly symptomatic after having had COVID-19 within the past 30 days,* antigen tests should be used to identify a new infection. CDCs COVID-19 Community Levels recommendations include implementing screening testing in high-risk settings at the medium and high levels. The SARS-CoV-2 Omicron variant emerged in late 2021 and spread quickly. To receive email updates about COVID-19, enter your email address: We take your privacy seriously. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Some tests provide results rapidly (within minutes); others require 1-3 days for processing. The correlation between neutralizing antibodies and anti-spike protein antibodies were estimated and tested using Spearman's correlation. This occurs when the test does not detect antibodies even though you may have antibodies for SARS-CoV-2. COVID-19 antibody testing is a blood test. Social determinants of health may influence access to testing. doi:10.1016/j.cell.2021.12.033. And staying inside to keep warm! The LJI team found that each antibody by itself could indeed reduce the viral load in the lungs in mice infected with SARS CoV-2 BA.1 and BA.2. How antibody swab testing can be useful However, now it seems that there are multiple enemies, with the emergence of variants like Delta and Omicron. An antibody test cannot be used to diagnose current COVID-19 because an antibody test does not detect SARS-CoV-2. Antibodies have two main parts: the arms and stem of the Y. Turnaround time is defined as the usual number of days from the date of pickup of a specimen for Yu F, Le MQ, Inoue S, et al. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. If you are concerned about your results, it is important to follow up with a healthcare provider, who can evaluate your medical history. You can view and print your results bysigning in or creatinga Labcorp Patient account. The decreased sensitivity of antigen tests might be offset if the POC antigen tests are repeated more frequently. This test provides semi-quantitative detection of serum antibodies against the spike glycoprotein of the SARS-CoV-2, the causative agent of COVID-19. In response, Labcorp has updated the reportable range of its semi-quantitative assay from 2500 Units/mL to 25,000 Units/mL to support reporting of levels higher levels of antibodies. Additional information regarding LOINC codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf. LA JOLLA, CAAn anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. 2023 Laboratory Corporation of America Holdings. Ordering: We are pleased to perform serology testing for all patients who have a valid provider order. SARS-CoV-2 is the name of the virus that causes coronavirus disease 2019 (COVID-19). Some tests may be able to be performed frequently because they are less expensive and easier to use than other tests, and supplies are readily available. Positive predictive values for SARS-CoV-2 antibody tests are impacted by how common SARS-CoV-2 antibodies are in the population being tested at a certain time. IgG antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Researchers mapped where various antibodies bind to the SARS-CoV-2 spike protein. People who have symptoms of COVID-19 or who have had known exposure to someone with COVID-19 should be tested for COVID-19. ThisCOVID-19 semi-quantitative test is for individuals who think they may have antibodies from infection or vaccination but who do not currently have symptoms of COVID-19. Each sample was assayed in triplicates. These tests can tell your physician that you have had an immune response to a virus or vaccine. Federal Tax ID Number 33-0328688. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. What are the numerical ranges reported? At this time, antibody test results should not be used to decide if you need a COVID-19 vaccine or a vaccine booster, or to determine whether your vaccine worked. Contact: commserv@uw.edu | While the test itself has no upfront costs if you are insured, there is a $6 non-refundable service fee to PWNHealth. How did this happen? These tests report whether SARS-CoV-2 antibodies were detected or not detected over a certain threshold, and this threshold may vary between different SARS-CoV-2 antibody tests. For the new study, the researchers began with a pool of antibodies from the San Diego volunteer. It also can take days to weeks after the infection for your body to make detectable antibodies. For more information, please view the literature below. However, the sniffles dont always mean COVID-19. Refers to point-of-care antigen tests only. Kontou et al. Antibodies are large Y shaped molecules produced by the B-Cells of your immune system. Assay for the Detection of Total Antibodies to SARS-CoV-2 They help us to know which pages are the most and least popular and see how visitors move around the site. Effective March 28, 2022, Labcorp expanded the reporting range of results for test number 164090 SARS-CoV-2 Semi-Quantitative Total Antibody, Spike. You have not been infected with SARS-CoV-2 previously. It also can show how your body reacted to COVID-19 vaccines. . The LOINC codes are copyright 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. FDA has provided additional information for healthcare providers who are using diagnostic tests in screening asymptomatic individuals, and the Centers for Medicare & Medicaid Services has exercised enforcement discretionunder the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to enable the use of antigen tests that are not currently authorized for use in asymptomatic individuals for the duration of the COVID-19 public health emergency. SARS-CoV-2 antibody tests detect antibodies to the SARS-CoV-2 virus. All persons (independent of vaccination status) with positive results should isolate at home or, if in a healthcare setting, be placed on appropriate precautions. The test result may be wrong, known as a "false negative." Results are reported as AU/mL. Antibody testing is being used for public health surveillance and epidemiologic purposes. The Moderna vaccine works by prompting the body to make the Spike proteinglimpses of the viral bullseyeso it can begin work on its antibodies and other weaponry against the real virus. It can take days to weeks after an infection for your body to make antibodies. Please see FDA guidanceon the use of at-home COVID-19 antigen tests. If you have questions about whether a SARS-CoV-2 antibody test is right for you, talk with your health care provider or your state or local health department.

New Hanover High School Student Death, Georgia Nursing Home Staffing Requirements, O'bravia Umbrella Replacement Parts, Articles C